We introduce MoRE-Net, a novel interpretable and modality-robust model for brain tumor grading. Experimental results demonstrate its strong performance in both diagnostic accuracy and interpretability under missing modality conditions, indicating its potential for clinical deployment.
Li et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: